PAF’s Co-Pay Relief Expands Critical Assistance in Response to Documented Patient Need
Assistance now available for both medical insurance premiums & prescription medication co-payments in some funds.
On May 10, 2021, PAF’s Co-Pay Relief (CPR) program will expand its assistance to cover medical insurance premium expenses incurred by those diagnosed with myelodysplastic syndrome, multiple myeloma, pulmonary fibrosis, and spinal muscular atrophy. In addition, each of these disease funds will have an increased annual grant award for new and renewing patients.
CPR puts patient and family peace of mind above all else and when results from a recent patient survey indicated that expenses associated with medical insurance premiums were causing financial distress for many of our Co-Pay Relief patients we responded.
What do these changes mean? Patients who are eligible for support through these four disease funds can now use their grant awards to cover both medical insurance premiums and prescription medication copayments. See below for additional detail:
- Medical insurance premium coverage:
- Current, new, and renewing patients receiving assistance from the funds below can use their award to reimburse for individual health insurance premiums, or to have their insurance premiums paid directly to their insurance provider.
- Increased annual award amounts:
- myelodysplastic syndrome: increased maximum annual award to $10,500
- multiple myeloma: increased maximum annual award to $12,000
- pulmonary fibrosis: increased maximum annual award to $9,000
- spinal muscular atrophy: increased maximum annual award to $6,500
To learn more, or to apply for assistance, please visit https://copays.org/funds/ or call our dedicated CPR staff toll-free at 866-512-3861. You take care of yourself. We’ll take care of the financial strain.